Home > Drug Search >
  • company_query: Adgero Biopharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (18) biology (6)
Status:
Approved (3) NDA Filing (1) Phase Ⅲ (5) Phase Ⅱ (7) Phase Ⅰ (8)
Clinical Stage:
Pending (2) Active (15) Discontinued (4)
Bio-Type:
Vaccine (3) Whole antibody (1)
Indication:
Attention deficit hyperactivity disorder (ADHD) (1) Breast cancer (2) Chronic obstructive pulmonary disease (COPD) (1) Cystic fibrosis (CF) (1) Dementia (1) Dry eye disease (1) Adult respiratory distress syndrome (ADRS) (1) HIV infection (1) Hyperlipidemia (1) Lung cancer (1) Melanoma (2) Neuropathic pain (1) Ovarian cancer (1) Parkinson's disease (PD) (1) Peptic ulcer (1) Pulmonary arterial hypertension (2) Colorectal cancer (1) Pulmonary sarcoidosis (1) Neuroblastoma (1) Pain (1) Ischemic stroke (1) Glioblastoma (2) Glioma (1) Bleeding (1) Dengue fever (1) Liver cancer (1) Chronic fatigue syndrome (1) Ocular inflammation (1)
Country:
Aprv. Year:
2002 (1) 2015 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top